Malignant disease in immunodeficient states in man.
作者信息
Penn I
出版信息
Recent Results Cancer Res. 1975(52):96-106. doi: 10.1007/978-3-642-80940-8_12.
PMID:796918
Abstract
摘要
相似文献
1
Malignant disease in immunodeficient states in man.
Recent Results Cancer Res. 1975(52):96-106. doi: 10.1007/978-3-642-80940-8_12.
2
Another look at immunologic surveillance.再看免疫监视。
N Engl J Med. 1975 Jul 24;293(4):181-4. doi: 10.1056/NEJM197507242930406.
3
Cancer is a complication of severe immunosuppression.
Surg Gynecol Obstet. 1986 Jun;162(6):603-10.
4
[Development of lymphoma and leukemia in patients receiving immunosuppressive drugs].
Pol Tyg Lek. 1980 Mar 17;35(11):411-4.
5
Depressed immunity and the development of cancer.免疫力低下与癌症的发生
Clin Exp Immunol. 1981 Dec;46(3):459-74.
6
Immunodeficiency and the pathogenesis of lymphoma and leukemia.免疫缺陷与淋巴瘤和白血病的发病机制。
Semin Hematol. 1978 Apr;15(2):117-38.
7
The occurrence of malignant tumors in immunosuppressed states.免疫抑制状态下恶性肿瘤的发生。
Prog Allergy. 1986;37:259-300. doi: 10.1159/000318448.
8
Tumour development following immunosuppression.免疫抑制后的肿瘤发展。
Proc R Soc Med. 1970 Oct;63(10):1077-80. doi: 10.1177/003591577006301055.
9
Immunosuppressive chemotherapy and malignancy.免疫抑制化疗与恶性肿瘤
Transplant Proc. 1974 Dec;6(4 Suppl 1):45-8.
10
Malignancy as a complication of immunosuppressive therapy.恶性肿瘤作为免疫抑制治疗的一种并发症。
Adv Intern Med. 1971;17:95-123.
引用本文的文献
1
Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.癌症与SARS-CoV-2引发的炎症、重叠功能及药物靶向治疗
Inflammopharmacology. 2021 Apr;29(2):343-366. doi: 10.1007/s10787-021-00796-w. Epub 2021 Mar 15.
2
Investigations on the influence of immunodepressive means on the chemical carcinogenesis in rats.
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974;81(3-4):211-5. doi: 10.1007/BF00305020.
Zotero 插件